PhaseBio Pharmaceuticals (PHAS) null Earnings

29AugConfirmed
Aug 18
-1.34
-0.89
-0.45
0

Details

Expected EPS
0
Actual EPS
-1.34
Surprise EPS
-1.34
Surprise Percent
+∞%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -1.34 per share for .

0 Comments

Share your thoughts